Cat.#: ASSD-145
Description | Oxazole Yellow iodide, a green fluorescent DNA marker, is a carbocyanine nucleic acid stain that has a strong binding affinity to nucleic acids. It is commonly used to identify apoptotic cells. YP1 does not penetrate the plasma membrane of viable cells. However, apoptotic processes cause the cell membrane to become slightly permeable, allowing YP1 to enter these cells and bind to nucleic acids to allow detection of apoptotic cells. |
Synonyms | Yo-Pro-1, YP1, YP-1 |
Size | 1 mL |
Applications | Frequently used with propidium iodide when staining for apoptotic and necrotic cells as apoptotic cells remain impermeant to propidium iodide but permeable to YP1. |
Chemical Name | 4-[(3-Methyl-2(3H)-benzoxazolylidene)methyl]-1-[3-(trimethylammonio)propyl]-quinolinium diiodide |
Molecule Weight | 629.32 |
Molecular formula | C24H29I2N3O |
CAS Number | 152068-09-2 |
PubChem identifier | 6439500 |
Form | Yellow Solution |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Important | We strongly recommend storing this product away from light. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-166 | FURA-2 (AC166) | 1 mg | inquiry |
ASSD-222 | Antifade Fluorescence Mounting Medium with Propidium Iodide (hard set) (AC222) | 10 mL | inquiry |
ASSD-136 | LUF7445/A2A antagonist (AC136) | 50 μg | inquiry |
ASSD-115 | 7-Amino-4-methylcoumarin (AC115) | 100 mg, 500 mg, 1 g | inquiry |
ASSD-120 | Fluorescent adenosine antagonist [XAC] (AC120) | 500 μg | inquiry |
ASSD-172 | Ionomycin free acid (AC172) | 1mg, 5mg | inquiry |
ASSD-113 | Thionin acetate salt (AC113) | 5 g | inquiry |
ASSD-148 | Sulforhodamine 101 (AC148) | 50 mg, 100 mg | inquiry |
ASSD-149 | D-Luciferin sodium salt (AC149) | 10 mg, 50 mg, 100 mg | inquiry |
ASSD-186 | Bromocresol Purple (AC186) | 5 g, 10 g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.